Clinical Trials List
Protocol NumberOBI-992-001
Active
2024-09-01 - 2027-06-30
Phase I/II
Not yet recruiting1
Recruiting1
-
Trial Applicant
OBI PHARMA, INC.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- HUI-WEN LIU Division of Hematology & Oncology
- 莊博雅 Division of Hematology & Oncology
- TSU-YI CHAO Division of Hematology & Oncology
- Yao-Yu Hsieh Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
39 participants
-
Global
117 participants
